Status:

ACTIVE_NOT_RECRUITING

Registry of Asthma Patients Initiating DUPIXENT®

Lead Sponsor:

Regeneron Pharmaceuticals

Collaborating Sponsors:

Sanofi

Conditions:

Asthma

Eligibility:

All Genders

12+ years

Brief Summary

The primary objective of the study is to characterize the patients who initiate treatment for asthma with DUPIXENT® in a real-world setting to understand the attributes of treated patients in real lif...

Detailed Description

3-year registry of real-world use of DUPIXENT® for asthma in patients age 12 and over

Eligibility Criteria

Inclusion

  • Key
  • Willing and able to comply with the required clinic visits, study procedures and assessments
  • Able to understand and complete study-related questionnaires
  • Provide signed informed consent; for patients under the age of 18, both parental (legal guardian) consent and patient assent are required
  • Initiating treatment with DUPIXENT® for a primary indication of asthma according to the country-specific prescribing information
  • Key

Exclusion

  • Patients who have a contraindication to DUPIXENT® according to the country-specific prescribing information
  • Treatment with dupilumab within 6 months before the screening visit, or within 6 months of the baseline visit if the screening and baseline occur on the same day
  • Any condition that, in the opinion of the investigator, may interfere with patient's ability to participate in the study or personal conditions and circumstances that can predictably prevent the patient from adequately completing the schedule of visits and assessments.
  • NOTE: Other protocol defined Inclusion/Exclusion criteria apply.

Key Trial Info

Start Date :

March 2 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 13 2026

Estimated Enrollment :

718 Patients enrolled

Trial Details

Trial ID

NCT04287621

Start Date

March 2 2020

End Date

May 13 2026

Last Update

April 22 2025

Active Locations (128)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 32 (128 locations)

1

Clinical Research Center of Alabama, LLC

Birmingham, Alabama, United States, 35209

2

Arizona Allergy & Immunology Research

Gilbert, Arizona, United States, 85234

3

Medical Research of Arizona, a Division of Allergy, Asthma & Immunology Associates, Ltd.

Scottsdale, Arizona, United States, 85251

4

Children's Hospital of Orange County

Orange, California, United States, 92868